Lidoject

Lidocaine Hydrochloride, the active ingredient in Lidoject, is a local anesthetic presented as a topical preparation for skin and mucous membrane use. It provides reversible nerve impulse blockade to relieve pain during minor skin procedures, superficial wound care, and mucosal irritation in adult patients. The formulation is intended for external application and is commonly employed in clinical settings to achieve rapid, localized numbness without systemic effects.

GNH USA supplies Lidoject as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidoject, a topical local anesthetic, is used to provide surface anesthesia in several clinical situations.

Minor skin procedures: provides localized numbness to facilitate biopsies, suturing or minor excisions. Superficial wound or irritation: relieves pain from cuts, abrasions or irritant contact. Mucous membranes: anesthetizes oral or nasal mucosa prior to minor interventions.

Lidoject may cause local or systemic adverse reactions following topical application.

Common Side Effects: - Transient burning or stinging at the application site - Mild erythema or redness - Pruritus or itching - Localized swelling - Dryness of the skin or mucosa - Temporary tingling sensation

Serious or Rare Side Effects: - Allergic contact dermatitis - Systemic toxicity presenting as dizziness, tinnitus, or seizures - Cardiac arrhythmia or conduction disturbances - Severe local tissue necrosis - Anaphylactic reaction - Methemoglobinemia (rare)

When using Lidoject, consider the following safety measures.

Allergy assessment: avoid use in patients with known lidocaine hypersensitivity. Application area: limit to intact skin or mucosa; do not apply to large surface areas. Concurrent anesthetics: avoid combining with other topical anesthetics to prevent cumulative toxicity. Medical conditions: use cautiously in patients with cardiac conduction disorders or severe liver disease. Pregnancy and lactation: consult a healthcare professional before use. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidoject can interact with other medications; monitor patients accordingly.

Major Interactions (Avoid): - Other amide‑type local anesthetics: may increase systemic toxicity. - Class I antiarrhythmic drugs (e.g., quinidine, procainamide): can potentiate cardiac effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise lidocaine plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance lidocaine's bradycardic effect. - Diuretics (e.g., furosemide): may affect plasma protein binding and increase free drug concentration.